| 产品编号 | 结构式 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A666731 |
| Anti-Factor IX & Factor X Reference Antibody (Emicizumab), Target:FactorIX&FactorX,Uniprot:P00740&P00742,Species:Human,isotype:IgG-like Anti-Factor IX & Factor X Reference Antibody (Emicizumab), Target:FactorIX&FactorX,Uniprot:P00740&P00742,Species:Human,isotype:IgG-like |
||
| A666730 |
| Anti-CD3 & GD2 Reference Antibody (Nivatrotamab), Target:CD3&GD2,Uniprot:P07766&NA,Species:Human,isotype:IgG-scFv Anti-CD3 & GD2 Reference Antibody (Nivatrotamab), Target:CD3&GD2,Uniprot:P07766&NA,Species:Human,isotype:IgG-scFv |
||
| A666729 |
| Anti-CA125 & CD3 Reference Antibody (Ubamatamab), Target:CA125&CD3,Uniprot:B5ME49&P07766,Species:Human,isotype:IgG-like Anti-CA125 & CD3 Reference Antibody (Ubamatamab), Target:CA125&CD3,Uniprot:B5ME49&P07766,Species:Human,isotype:IgG-like |
||
| A666728 |
| Anti-Ang2 & VEGFA Reference Antibody (Vanucizumab), Target:Angiopoietin2&VEGF,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like Anti-Ang2 & VEGFA Reference Antibody (Vanucizumab), Target:Angiopoietin2&VEGF,Uniprot:Q9UID3&P15692,Species:Human,isotype:IgG-like |
||
| A666727 |
| Anti-CD19 & CD3 Reference Antibody (Blinatumomab), Target:CD19&CD3,Uniprot:P15391&P07766,Species:Human,isotype:BiTE Anti-CD19 & CD3 Reference Antibody (Blinatumomab), Target:CD19&CD3,Uniprot:P15391&P07766,Species:Human,isotype:BiTE |
||
| A666726 |
| Anti-CTLA4 & PD-1 Reference Antibody (Vudalimab), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-scFv Anti-CTLA4 & PD-1 Reference Antibody (Vudalimab), Target:CTLA4&PD-1,Uniprot:P16410&Q15116,Species:Human,isotype:IgG-scFv |
||
| A666725 |
| Anti-HER2/neu & HER3 Reference Antibody (Zenocutuzumab), Target:HER2/neu&HER3,Uniprot:P04626&P21860,Species:Human,isotype:IgG-like Anti-HER2/neu & HER3 Reference Antibody (Zenocutuzumab), Target:HER2/neu&HER3,Uniprot:P04626&P21860,Species:Human,isotype:IgG-like |
||
| A666724 |
| Anti-PD-1 & TIM-3 Reference Antibody (Lomvastomig), Target:PD-1&TIM-3,Uniprot:Q15116&Q8TDQ0,Species:Human,isotype:IgG-like Anti-PD-1 & TIM-3 Reference Antibody (Lomvastomig), Target:PD-1&TIM-3,Uniprot:Q15116&Q8TDQ0,Species:Human,isotype:IgG-like |
||
| A666723 |
| Anti-CD3 & DLL3 Reference Antibody (Tarlatamab), Target:CD3&DLL3,Uniprot:P07766&Q9NYJ7,Species:Human,isotype:HLE-BiTE Anti-CD3 & DLL3 Reference Antibody (Tarlatamab), Target:CD3&DLL3,Uniprot:P07766&Q9NYJ7,Species:Human,isotype:HLE-BiTE |
||
| A666722 |
| Anti-CD3 & EpCAM Reference Antibody (M701), Target:CD3&EpCAM,Uniprot:P07766&P16422,Species:Human,isotype:IgG-scFv Anti-CD3 & EpCAM Reference Antibody (M701), Target:CD3&EpCAM,Uniprot:P07766&P16422,Species:Human,isotype:IgG-scFv |
||
| A666721 |
| Anti-CD28 & PSMA Reference Antibody (Nezastomig), Target:CD28&PSMA,Uniprot:P10747&Q04609,Species:Human,isotype:IgG-like Anti-CD28 & PSMA Reference Antibody (Nezastomig), Target:CD28&PSMA,Uniprot:P10747&Q04609,Species:Human,isotype:IgG-like |
||
| A666720 |
| Anti-CD123 & CD3 Reference Antibody (Flotetuzumab), Target:CD3&CD123,Uniprot:P26951&P07766,Species:Human,isotype:DART-DART Anti-CD123 & CD3 Reference Antibody (Flotetuzumab), Target:CD3&CD123,Uniprot:P26951&P07766,Species:Human,isotype:DART-DART |